289 related articles for article (PubMed ID: 34887218)
1. A descriptive study of inflammatory bowel disease at an Egyptian tertiary care center.
El-Atrebi KA; Taher E; El Aguizy FH; Ali RM; Hegazy A; El-Sayed MM; Eysa B; El-Atreby AA; Mohammed AA; El-Bassyouni HT
Rev Gastroenterol Mex (Engl Ed); 2023; 88(1):12-18. PubMed ID: 34887218
[TBL] [Abstract][Full Text] [Related]
2. Epidemiological and clinical characteristics of inflammatory bowel diseases in Cairo, Egypt.
Esmat S; El Nady M; Elfekki M; Elsherif Y; Naga M
World J Gastroenterol; 2014 Jan; 20(3):814-21. PubMed ID: 24574754
[TBL] [Abstract][Full Text] [Related]
3. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
[TBL] [Abstract][Full Text] [Related]
4. Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients.
Juliao-Baños F; Kock J; Arrubla M; Calixto O; Camargo J; Cruz L; Hurtado J; Clavijo A; Donado J; Schwartz S; Abreu MT; Damas OM
Medicine (Baltimore); 2021 Feb; 100(7):e24729. PubMed ID: 33607817
[TBL] [Abstract][Full Text] [Related]
5. Clinical and therapeutic characterisation of a multicentre cohort of patients with inflammatory bowel disease in Colombia.
Parra-Izquierdo V; Flórez Sarmiento C; Frías-Ordoñez JS; Vargas M; Kock J; Lozano Escobar N; Márquez JR
Gastroenterol Hepatol; 2023 Oct; 46(8):585-593. PubMed ID: 36464080
[TBL] [Abstract][Full Text] [Related]
6. Real-World Treatment Patterns and Healthcare Resource Use for Ulcerative Colitis and Crohn's Disease in Italy.
Dovizio M; Hartz S; Buzzoni C; Redondo I; Nedeljkovic Protic M; Birra D; Perrone V; Veronesi C; Degli Esposti L; Armuzzi A
Adv Ther; 2024 Jun; 41(6):2282-2298. PubMed ID: 38619721
[TBL] [Abstract][Full Text] [Related]
7. Suboptimal response to tumor necrosis factor antagonists in inflammatory bowel disease in Latin America: EXPLORE LATAM study.
Balderramo D; Yamamoto-Furusho J; Ponce de León E; de María J; Zubiaurre I; Pedreira S; Lis C; Brion L; de Paula JA
Gastroenterol Hepatol; 2024 Jan; 47(1):51-62. PubMed ID: 37062500
[TBL] [Abstract][Full Text] [Related]
8. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
[TBL] [Abstract][Full Text] [Related]
9. Association between inflammatory bowel disease and subsequent depression or anxiety disorders - A retrospective cohort study of 31,728 outpatients.
Roderburg C; Yaqubi K; Konrad M; May P; Luedde T; Kostev K; Loosen SH
J Psychiatr Res; 2024 Jan; 169():231-237. PubMed ID: 38048672
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation.
Yamamoto-Furusho JK; Bosques-Padilla F; de-Paula J; Galiano MT; Ibañez P; Juliao F; Kotze PG; Rocha JL; Steinwurz F; Veitia G; Zaltman C
Rev Gastroenterol Mex; 2017; 82(1):46-84. PubMed ID: 27979414
[TBL] [Abstract][Full Text] [Related]
11. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China.
Jiang L; Xia B; Li J; Ye M; Yan W; Deng C; Ding Y; Luo H; Hou W; Zhao Q; Liu N; Ren H; Hou X; Xu H
Inflamm Bowel Dis; 2006 Mar; 12(3):212-7. PubMed ID: 16534423
[TBL] [Abstract][Full Text] [Related]
12. Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study.
Biancone L; Zuzzi S; Ranieri M; Petruzziello C; Calabrese E; Onali S; Ascolani M; Zorzi F; Condino G; Iacobelli S; Pallone F
J Crohns Colitis; 2012 Jun; 6(5):578-87. PubMed ID: 22398047
[TBL] [Abstract][Full Text] [Related]
13. Lower urinary tract symptoms in patients with inflammatory bowel diseases: A cross-sectional observational study.
Romano L; Pellegrino R; Arcaniolo D; Gravina AG; Miranda A; Priadko K; De Gennaro N; Santonastaso A; Palladino G; Crocetto F; Barone B; Cuomo A; Facchiano A; Mucherino C; Spirito L; Sciorio C; de Sio M; Romano M; Napolitano L
Dig Liver Dis; 2024 Apr; 56(4):628-634. PubMed ID: 37880017
[TBL] [Abstract][Full Text] [Related]
14. Special situations in inflammatory bowel disease: First Latin American consensus of the Pan American Crohn's and Colitis Organisation (PANCCO) (Second part).
Yamamoto-Furusho JK; Bosques-Padilla F; Daffra P; De Paula JA; Etchevers J; Galiano MT; Ibañez P; Juliao F; Kotze PG; Marroquín de la Garza JM; Monreal Robles R; Rocha JL; Steinwurz F; Vázquez-Frías R; Veitia G; Zaltman C
Rev Gastroenterol Mex; 2017; 82(2):134-155. PubMed ID: 28318706
[TBL] [Abstract][Full Text] [Related]
15. [Immune-mediated inflammatory diseases in patients with inflammatory bowel disease. Baseline data from the Aquiles study].
Marín-Jiménez I; García Sánchez V; Gisbert JP; Lázaro Pérez Calle J; Luján M; Gordillo Ábalos J; Tabernero S; Juliá B; Romero C; Cea-Calvo L; García-Vicuña R; Vanaclocha F
Gastroenterol Hepatol; 2014 Nov; 37(9):495-502. PubMed ID: 24717523
[TBL] [Abstract][Full Text] [Related]
16. Thirty-year Trend in Inflammatory Bowel Disease on Jeju Island, South Korea.
Kim JW; Song HJ; Boo SJ; Kim HU; Kang KS; Na SY
Korean J Gastroenterol; 2023 Jun; 81(6):243-252. PubMed ID: 37350519
[TBL] [Abstract][Full Text] [Related]
17. Incidence and phenotype at diagnosis of inflammatory bowel disease. Results in Spain of the EpiCom study.
Fernández A; Hernández V; Martínez-Ares D; Sanromán L; de Castro ML; Pineda JR; Carmona A; González-Portela C; Salgado C; Martínez-Cadilla J; Pereira S; García-Burriel JI; Vázquez S; Rodríguez-Prada I;
Gastroenterol Hepatol; 2015 Nov; 38(9):534-40. PubMed ID: 25890448
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory bowel disease: A descriptive study of 716 local Chilean patients.
Simian D; Fluxá D; Flores L; Lubascher J; Ibáñez P; Figueroa C; Kronberg U; Acuña R; Moreno M; Quera R
World J Gastroenterol; 2016 Jun; 22(22):5267-75. PubMed ID: 27298570
[TBL] [Abstract][Full Text] [Related]
19. Duration of smoking cessation in patients with inflammatory bowel disease.
González-Muñoza C; Gely C; Gordillo J; Bertoletti F; Giordano A; López-Faba A; García-Planella E
Gastroenterol Hepatol; 2024; 47(6):591-597. PubMed ID: 37977427
[TBL] [Abstract][Full Text] [Related]
20. Cancer risk in patients with inflammatory bowel disease: a population-based study.
Bernstein CN; Blanchard JF; Kliewer E; Wajda A
Cancer; 2001 Feb; 91(4):854-62. PubMed ID: 11241255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
